Clinical Trial Update: Evaluate Safety and Efficacy of ABT-335 in Combination With Simvastatin in Subjects With Multiple Abnormal Lipid Levels in the Blood [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ABT-335 in combination with simvastatin for dyslipidemia and coronary heart disease has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Heart Disease
• Dyslipidemia

Drugs mentioned

• ABT-335
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Abbott | Conditions: Dyslipidemia, Coronary Heart Disease | Phase 3 | Status: COMPLETED | Results posted: 2009-03-25